文献速递腹部MR

钆塞酸二钠增强MRI预测肝细胞癌VETC亚型及比例的预后价值

Predictive value of Gd-EOB-DTPA-enhanced MRI features for VETC subtypes and proportions and their combined prognostic significance in hepatocellular carcinoma.
PubMed 文献 · Eur J Radiol · 2026-09-03

回顾性纳入211例术前接受钆塞酸二钠增强MRI的肝细胞癌患者,用Logistic回归分析VETC亚型和比例的预测因素,Cox回归评估预后意义。结果显示卫星结节、低动脉期强化比及AFP升高可独立预测MaT-VETC,完全强化包膜、肝胆期信号比低和病灶较小可预测高VETC比例。MaT-VETC与总生存期缩短独立相关,VETC比例则仅呈非显著趋势。

要点

  • 卫星结节和低动脉期强化比为MaT-VETC的独立预测因素,报告时应重点关注
  • 完全强化包膜、肝胆期低信号比及病灶较小提示高VETC比例
  • AFP≥300 µg/L同时预测MaT-VETC和高VETC比例,可辅助风险分层

核心结论

  • MaT-VETC是肝细胞癌总生存期缩短的独立预测因素(aHR 2.84,95% CI 1.03-7.78,p=0.043)
  • 高VETC比例与生存期缩短无显著统计学关联(aHR 2.07,95% CI 0.78-5.48,p=0.143)
  • 术前钆塞酸二钠增强MRI特征联合AFP可无创识别VETC亚型及比例,结论需外部验证

研究设计与样本

  • 回顾性研究,纳入211例病理确诊且术前行钆塞酸二钠增强MRI的肝细胞癌患者
  • 病例采集时间为2015年1月至2024年12月,按探索性VETC亚型和比例分层
  • 采用Logistic回归筛选预测影像征象,Cox回归整合影像及临床病理指标评估预后

关键影像表现/征象

  • 卫星结节独立预测MaT-VETC(aOR 4.54,95% CI 1.46-14.08,p=0.009)
  • 低动脉期强化比独立预测MaT-VETC(aOR 3.33,95% CI 1.22-9.17,p=0.019)
  • 完全强化包膜独立预测高VETC比例(aOR 2.63,95% CI 1.46-4.79,p=0.001)
  • 肝胆期病灶/肝信号比降低与高VETC比例相关(aOR 0.17,95% CI 0.06-0.52,p=0.002)
  • 病灶较小独立预测高VETC比例(aOR 0.51,95% CI 0.28-0.94,p=0.031)

诊断标准与关键数值

  • MaT-VETC定义为VETC≥6层,其独立预测因素、aOR值及95% CI均基于上述Logistic回归模型
  • 高VETC比例的预测因素包括完全强化包膜、肝胆期信号比降低和病灶较小,具体阈值原文未给出
  • AFP≥300 µg/L同时预测MaT-VETC(aOR 3.55,95% CI 1.12-11.27,p=0.031)和高VETC比例(aOR 2.32,95% CI 1.28-4.23,p=0.006)

临床应用与阅片要点

  • 阅片时遇到动脉期强化低的肝细胞癌且伴有卫星结节,应警惕MaT-VETC亚型可能
  • 完全强化包膜配合肝胆期信号明显减低和病灶较小,可作为高VETC比例的影像提示
  • AFP≥300 µg/L患者无论影像表现如何,均应纳入VETC相关高危分层考虑

局限性

  • 本研究为初步探索性研究,结论需更大规模外部队列验证后方可临床应用
  • 回顾性单中心设计存在选择偏倚,VETC比例的阈值未在原文明确给出

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To identify preoperative Gd-EOB-DTPA-enhanced MRI features and clinical variables predictive of an exploratory subtype and proportion of vessels encapsulating tumor clusters (VETC) in hepatocellular carcinoma (HCC), and to evaluate their preliminary prognostic value.

METHODS: This retrospective study included 211 patients with pathologically confirmed HCC who underwent preoperative Gd-EOB-DTPA-enhanced MRI (January 2015-December 2024). Patients were classified by exploratory VETC subtype and proportion. Predictive imaging features were identified using logistic regression, and the prognostic implications of VETC-based stratification were assessed by integrating relevant imaging and clinicopathological indices using Cox regression.

RESULTS: Macrotrabecular-VETC (MaT-VETC) (≥6 layers) was independently associated with satellite nodules (aOR 4.54, 95% CI: 1.46-14.08; p = 0.009) and low arterial-phase enhancement ratio (aOR 3.33, 95% CI: 1.22-9.17; p = 0.019). A complete enhancing capsule (aOR 2.63, 95% CI: 1.46-4.79; p = 0.001), lower hepatobiliary phase lesion-to-liver signal ratio (aOR 0.17, 95% CI: 0.06-0.52; p = 0.002), and smaller lesion size (aOR 0.51, 95% CI: 0.28-0.94; p = 0.031) independently predicted higher VETC proportion. Elevated AFP (≥300 µg/L) predicted both MaT-VETC (aOR 3.55, 95% CI: 1.12-11.27; p = 0.031) and higher VETC proportion (aOR 2.32, 95% CI: 1.28-4.23; p = 0.006). MaT-VETC was independently associated with worse overall survival (aHR 2.84, 95% CI: 1.03-7.78; p = 0.043), whereas higher VETC proportion showed a nonsignificant trend toward shorter survival (aHR 2.07, 95% CI: 0.78-5.48; p = 0.143).

CONCLUSIONS: Preoperative Gd-EOB-DTPA-enhanced MRI features and elevated AFP were associated with an exploratory, endothelial-caliber-based VETC subtype and with VETC proportion in HCC. MaT-VETC, but not VETC proportion, showed an association with worse overall survival in this preliminary study; these hypothesis-generating findings require validation in larger, external cohorts before clinical application.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang, Song, Du, et al. Predictive value of Gd-EOB-DTPA-enhanced MRI features for VETC subtypes and proportions and their combined prognostic significance in hepatocellular carcinoma. Eur J Radiol. 2026. PMID: 42715897. doi:10.1016/j.ejrad.2026.113209

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。